Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2001
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof
03/28/2001CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
03/28/2001CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/28/2001CN1288886A Felodipine producing technology
03/28/2001CN1063748C Naphthalene derivatives, process for preparation thereof and intermediates thereof
03/27/2001US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma
03/27/2001US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection
03/27/2001US6207688 Treating multi-drug resistant, non-nucleoside reverse transcriptase resistant, and therapy naive hiv infection by administering phenethyl-thiourea derivative
03/27/2001US6207363 Cyan ?nb coupler?
03/27/2001US6206819 Low volatility substituted n,n diformamides as halogenation catalysts for transforming organic hydroxyl, thiol, aldehyde, and carboxy groups to organohalides
03/22/2001WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors
03/22/2001WO2001019798A2 INHIBITORS OF FACTOR Xa
03/22/2001WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
03/22/2001WO2001019784A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries
03/22/2001WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
03/22/2001WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/22/2001WO2001019770A2 Rxr modulators with improved pharmacologic profile
03/22/2001WO2000061134A8 Antimicrobial agents
03/22/2001WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection
03/22/2001WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors
03/22/2001CA2672722A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries
03/22/2001CA2385589A1 Inhibitors of factor xa
03/22/2001CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001CA2383565A1 Rxr modulators with improved pharmacologic profile
03/21/2001EP1085371A1 Photographic material containing a novel hydrazide type
03/21/2001EP1085370A1 Photographic material containing a novel hydrazide type
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001EP1085009A1 Indan derivatives
03/21/2001EP1084119A1 Aromatic amine derivatives as pharmaceutical agents
03/21/2001EP1084118A1 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4- 4-(4pyridyl) benzoyl] piperazine
03/21/2001EP1084117A2 Novel herbicides
03/21/2001EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
03/21/2001EP1083921A1 Novel leukotriene receptor antagonists and their uses
03/21/2001EP1083917A1 Novel analgesic agents
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/21/2001EP0717616B1 Process for conditioning substances
03/21/2001EP0613466B1 Organic compounds
03/21/2001CN1288459A Organic nitrile derivatives and their use as pesticides
03/21/2001CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion
03/21/2001CN1288380A Utilization of powder prepns. contg. hydroxypyridones treating LEG ulcer and decubitus ulcers
03/21/2001CN1288005A Method for preparing 2-phenyl-3-aminopyridine, and the substituled phenyl derivatives and salts thereof
03/21/2001CN1288002A Method for preparing biocide alkyl-substituted (hetero)-aryl-ketoxime-o-ether and its intermediate ketone or oxime compounds
03/21/2001CN1063432C N-substituted Cis-Propenyl-acetamides and process for their preparation
03/21/2001CN1063430C Ethanolamine derivatives
03/20/2001US6204387 Process for making diaryl pyridines useful as COX-2 inhibitors
03/20/2001US6204386 Method for esterification of carboxylic or polycarboxylic acid in the presence of supercritical fluids and catalysts therefor
03/20/2001US6204385 Reacting the corresponding nitrile with ammonia, amine or hydrazine in the presence of a mercaptocarboxylic acid
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/20/2001US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols
03/20/2001US6204277 Treating diabetes
03/20/2001US6204276 Dicarboxylic germanium complex and its therapeutic use
03/20/2001US6204275 PDE IV inhibiting compounds, compositions and methods of treatment
03/20/2001US6204221 For controlling weeds in crops
03/20/2001CA2213111C Substituted carboxanilide derivative and plant disease control agent comprising same as active ingredient
03/20/2001CA2071529C Diaromatic substituted anti-aids compounds
03/15/2001WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001WO2001018008A2 Decahydronaphthalene derivatives for molecular signal transduction
03/15/2001WO2001017999A2 Amino-triazolopyridine derivatives
03/15/2001WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase
03/15/2001WO2001017970A1 Process for the preparation of 2-cyanopyridines
03/15/2001WO2001017969A1 6-[(substituted or unsubstituted)phenoxy]picolinic acid ureide derivatives, process for producing the same and herbicides
03/15/2001WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives
03/15/2001WO2001017967A1 TRANSITION METAL COMPOUNDS, CATALYSTS FOR THE PRODUCTION OF α-OLEFINS AND PROCESS THEREFOR
03/15/2001WO2001017964A1 Tetrahydropyridines as pesticides
03/15/2001WO2001017959A2 Vitronectin receptor antagonists
03/15/2001WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/15/2001WO2001017955A2 Hydroxyacetamidobenzenesulphonamide derivatives
03/15/2001WO2001017530A1 Iron chelators and uses thereof
03/15/2001WO2000075113A8 Novel heterocyclic carboxamide derivatives
03/15/2001WO2000053583A8 Inhibitors of protein tyrosine phosphatase
03/15/2001WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
03/15/2001WO2000049007A8 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
03/15/2001WO1999065870A3 Sulfonamide inhibitors of aspartyl protease
03/15/2001DE4092096C1 1,4-Disubstituierte 2,6-Difluorbenzolverbindungen und flüssigkristallines Medium 1,4-Disubstituted 2,6-Difluorbenzolverbindungen and liquid crystalline medium
03/15/2001DE19944892A1 Dekalinderivate zur molekularen Signaltransduktion Decalin derivatives of molecular signal transduction
03/15/2001DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties
03/15/2001DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties
03/15/2001DE19942812A1 Verfahren zur Herstellung von D-(3'-Pyridyl)-alanin Process for the preparation of D- (3'-pyridyl) -alanine
03/15/2001DE19941559A1 Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie Using Bissulfonamiden for the preparation of medicaments for the prophylaxis or treatment of Hyperlipidömie
03/15/2001CA2384671A1 Vitronectin receptor antagonists
03/15/2001CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001CA2383998A1 Amino-triazolopyridine derivatives
03/15/2001CA2383782A1 Compounds for the treatment of viral infections
03/15/2001CA2383721A1 Use of 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogues as iron chelators
03/15/2001CA2381581A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/15/2001CA2381176A1 Process for the preparation of 2-cyanopyridines
03/15/2001CA2381003A1 Tetrahydropyridines as pesticides
03/15/2001CA2347385A1 Transition metal compounds, catalysts for the production of .alpha.-olefins and process therefor
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1083170A1 Method for producing D-(3'-Pyridyl)-alanine
03/14/2001EP1082960A2 Use of CRF antagonists and related compositions for treating depression and modifying the circadian rhytm
03/14/2001EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors